This page shows the latest Relvar news and features for those working in and with pharma, biotech and healthcare.
Relvar (fluticasone furoate/vilanterol) which became the first once-daily product of its type, have injected more competition into the marketplace.
But respiratory drug given the thumbs up for adults only
The product is sold as Relvar in some markets and is a follow-up to GSK's blockbuster Seretide/Advair product and combines LABA vilanterol with the inhaled corticosteroid (ICS) fluticasone
up Relvar/Breo (fluticasone furoate and vilanterol) - to get off to a flying start in the increasingly competitive respiratory sector.
combination Anoro (umeclidinium and vilanterol) and Advair follow-up Relvar/Breo (fluticasone furoate and vilanterol) - to get the division back on track.
All three drugs will be delivering via GSK's Ellipta inhaler, which is already used in the company's recently introduced dual therapies Anoro (umeclidinium and vilanterol) and Relvar/Breo (fluticasone
More from news
Approximately 2 fully matching, plus 23 partially matching documents found.